Sutro Biopharma Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Analysis

Sutro Biopharma, Inc. (STRO)

25.29 +2.79 (+12.40%) USD | NASDAQ | Mar 06, 16:00

25.24 -0.05 (-0.20%) Pre-Market: 20:00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for STRO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

Start Trial

GT Biopharma, Inc.	--
Rhythm Pharmaceuticals, Inc.	Upgrade
Crinetics Pharmaceuticals, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade